Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Moehler, Markus; Ryu, Min-Hee; Dvorkin, Mikhail et al.
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study designFUTURE ONCOLOGY. Bd. 15. H. 6. 2019 S. 567-577
Catenacci, Daniel; Rosales, Minori; Wigginton, Jon et al.
Margetuximab combined with anti-PD-1 (MGA012) or anti-PD-1/LAG-3 (MGD013) +/- chemotherapy in first-line therapy of advanced/metastatic HER2+gastroesophageal junction (GEJ) or gastric cancer (GC)JOURNAL FOR IMMUNOTHERAPY OF CANCER. Bd. 7. 2019
Ruecker, Frank G.; Agrawal, Mridul; Corbacioglu, Andrea et al.
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study GroupBLOOD. Bd. 134. H. 19. 2019 S. 1608-1618
Schlenk, Richard F.; Weber, Daniela; Fiedler, Walter et al.
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITDBLOOD. Bd. 133. H. 8. 2019 S. 840-851
Ahmed, Shakil; Chowdhury, Ezharul Hoque; Zimmermann, Tim et al.
MOLECULAR ENDOSCOPIC IMAGING FOR TARGETED VISUALIZATION OF CELL ADHESION MOLECULES IN PATIENTS WITH LIVER CIRRHOSISGASTROINTESTINAL ENDOSCOPY. Bd. 89. H. 6. 2019 S. AB634-AB635
Ahmed, Shakil; Galle, Peter R.; Neumann, Helmut
Molecular endoscopic imaging: the future is brightTHERAPEUTIC ADVANCES IN GASTROINTESTINAL ENDOSCOPY. Bd. 12. 2019
Heesen, Ludwig; Frenzel, Katrin; Bolte, Stefanie et al.
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)CANCER RESEARCH. Bd. 79. H. 13. 2019
Sasca, Daniel; Szybinski, Jakub; Schueler, Andrea et al.
NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AMLBLOOD. Bd. 133. H. 21. 2019 S. 2305-2319
Hasenburg, A.
Neoadjuvant Chemotherapy for Ovarian Cancer?GYNAKOLOGE. Bd. 52. H. 9. 2019 S. 638-638
Wahl, Alisha; Nagel, Michael; Labenz, Christian et al.
NON-ALCOHOLIC FATTY LIVER DISEASE IS HIGHLY PREVALENT IN PATIENTS LIVING WITH HUMAN DEFICIENCY VIRUS (HIV) IN GERMANY.HEPATOLOGY. Bd. 70. 2019 S. 1084A-1084A